Iradimed Corp
(IRMD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,125 | 3,258 | 1,488 | 2,050 | 1,780 |
| Depreciation Amortization | 164 | 106 | 51 | 149 | 100 |
| Accounts receivable | -1,484 | -2,359 | -1,601 | 131 | 771 |
| Accounts payable and accrued liabilities | 288 | 306 | 152 | 202 | 213 |
| Other Working Capital | -416 | -1,201 | -753 | -124 | 1,029 |
| Other Operating Activity | 1,406 | 2,629 | 1,719 | 178 | -404 |
| Operating Cash Flow | $5,083 | $2,739 | $1,056 | $2,586 | $3,487 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -7,696 | 252 |
| PPE Investments | -207 | -127 | -41 | -606 | -526 |
| Investing Cash Flow | $-207 | $-127 | $-41 | $-8,303 | $-274 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 321 | 199 | 192 | 14,595 | 14,490 |
| Other Financing Activity | 878 | 162 | 113 | -1,885 | -2,051 |
| Financing Cash Flow | $1,199 | $361 | $304 | $12,710 | $12,439 |
| Beginning Cash Position | 9,454 | 9,454 | 9,454 | 2,462 | 2,462 |
| End Cash Position | 15,529 | 12,428 | 10,774 | 9,454 | 18,114 |
| Net Cash Flow | $6,075 | $2,973 | $1,319 | $6,993 | $15,652 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,083 | 2,739 | 1,056 | 2,586 | 3,487 |
| Capital Expenditure | -207 | -127 | -41 | -606 | -526 |
| Free Cash Flow | 4,876 | 2,612 | 1,015 | 1,979 | 2,961 |